BIOS | · 9 min read By: Alix Ventures — Supporting Early Stage Life Science Startups Driving Patient Impact Intro It’s no secret that the traditional drug discovery model is expensive, time-consuming, and has recently produced compounds with marginal efficacy in clinical trials and high failure rates. Large biopharma companies are increasingly outsourcing R&D to academic labs and small/mid-size startups via licensing partnerships […]
How Machine Learning is Transforming Drug Discovery
STANFORD ENGINEERING STAFF November 10, 2020 Daphne Koller, a veteran of AI, explains why she left academia for a chance to change the pharmaceutical industry. STOCKSY/SERGIO MARCOS How can AI influence medicine and biology? In a world where a drug takes years and billions of dollars to develop, just one in 20 candidates makes it to […]